(Press-News.org) Women with low bone density are seven times more likely to benefit from a bisphosphonate drug when their vitamin D blood levels are above recent recommendations from the Institute of Medicine (IOM) as adequate for bone health. These new study results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.
"Maintaining adequate vitamin D levels above those recently recommended by the IOM is important for optimizing a standard therapy for osteoporosis: bisphosphonates," said coauthor Richard Bockman, MD, PhD, chief of the endocrine service at Hospital for Special Surgery and professor of medicine at Weill Cornell Medical College, both in New York City.
Last November the Institute of Medicine (IOM) issued its recommendations on vitamin D intake, reporting that most adults up to age 70 need no more than 600 International Units, or IU, a day to maintain bone health. According to the IOM, this intake, along with adequate calcium, is enough to achieve the minimum adequate vitamin D blood level, measured as serum 25-hydroxyvitamin D, which is 20 nanograms per milliliter (ng/mL).
However, in Bockman's study of 160 postmenopausal women with osteoporosis, an average 25-hydroxyvitamin D level of 20 to 30 ng/mL was associated with a high likelihood of not responding to at least 18 months of bisphosphonate treatment. Patients took alendronate, risedronate, ibandronate or zolendronate. The rate of women who were "nonresponders" at this serum vitamin D level was 77.8 percent, compared with 42.3 percent when serum vitamin D was in the range of 30 to 40 ng/mL. Only 24.6 percent were "nonresponders" for a level above 40 ng/mL, the authors reported.
Patients with a hydroxyvitamin D level of 33 ng/mL and above had a sevenfold greater likelihood of having a favorable response to bisphosphonate therapy than below that level, they found.
"This value of at least 33 ng/mL is higher than the level considered as "adequate" by the Institute of Medicine report for the general population and most likely requires a vitamin D intake higher than 600 IU for this therapeutic outcome," Bockman said. "In the future, I think we're going to see vitamin D recommendations based on specific conditions."
The researchers categorized patients as nonresponders if they had a new fracture while receiving a bisphosphonate or if their low bone density worsened by more than 3 percent as shown on dual-energy x-ray absorptiometry (DEXA) bone density scans obtained 18 to 60 months apart. Also counted as a nonresponder was any woman with a persistently low DEXA T-score worse than -3 (3 standard deviations below normal).
A typical nonresponse rate to bisphosphonate treatment, according to Bockman, is about 30 percent in an osteoporosis specialty clinic, such as the one from which participants in this study were recruited. Doctors do not generally measure a patient's serum vitamin D level before beginning bisphosphonate treatment, he said.
###
This study received funding through a fellowship from the New York Academy of Medicine and a center grant from the National Institutes of Health.
Low vitamin D levels are related to decreased response to osteoporosis medicine
2011-06-07
ELSE PRESS RELEASES FROM THIS DATE:
Desserts with a low glycemic index may benefit weight-loss efforts for obese children
2011-06-07
Overweight girls lose more weight and can better stay on a healthy diet if they eat sugar-free, low-fat desserts several times weekly, as opposed to any dessert once a week, a new study finds. The results will be reported Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
"Dieters commonly splurge on dessert once a week, usually choosing fattening items," said lead investigator Antonia Dastamani, MD, PhD, a pediatrician and research fellow at Athens University School of Medicine in Athens, Greece. "However, we found a positive effect of more frequent consumption ...
Testosterone therapy improves memory in postmenopausal women
2011-06-07
Post-menopausal women have better memory after daily treatment with a testosterone spray for six months, a new preliminary study finds. The results will be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston.
"Women have a higher risk of developing dementia compared to men," said Sonia Davison, MD, PhD, the study's lead investigator and a postdoctoral research fellow at Monash University, Melbourne. "These results offer a potential therapy, where none currently exists, to slow cognitive decline in women."
The researchers compared a control group ...
Father's Day 2011: Children's Book Author Dad, Grandfather Regales His Children and Grandchildren with 'Wanda and the Oblahlahs' Story, Lost in Attic for 35 Years
2011-06-07
This Father's Day, Joe Sutton's charming children's tale starring Wanda, a mischievous, gum-chewing yet lovable little girl, launches, giving a nod to the lost art of storytelling -- passing stories, family histories and values from one generation to the next. "Wanda and the Oblahlahs", (Bright Sky Press, September 2011), the brainchild of then Army Colonel Sutton, emerged at bedtime for his rambunctious young daughters, Gretchen and Megan. Now 35 years later, Wanda's imaginative adventure lives on for Sutton's grandchildren and, as a children's book, can share ...
Yearly zoledronic acid at lower-than-standard doses increases bone density
2011-06-07
A lower dose of zoledronic acid than currently recommended for prevention of bone fractures due to osteoporosis decreases bone resorption and increases bone density, and may be effective in reducing the risk of osteoporotic fractures, a study finds. The new research findings will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
"Our research suggests that one fifth or one half of the recommended dose might be sufficient to decrease fracture risk," said Andrew Grey, MD, principal investigator of the study and an associate professor of medicine ...
Yo-yo dieting appears to be healthier than lifelong obesity
2011-06-07
A new study comparing lifelong obesity with the weight fluctuations of "yo-yo dieting" suggests it is better to attempt to lose weight despite repeated failures at keeping the weight off than to not diet and remain obese. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston.
"It is clear that remaining on a stable, healthy diet provides the best outcome for health and longevity," said the study's principal investigator, Edward List, PhD, a scientist at Ohio University, Athens. "However, obese individuals commonly weight cycle—they ...
High amounts of the hormone leptin are linked to decreased depression
2011-06-07
Women who have higher levels of the appetite-controlling hormone leptin have fewer symptoms of depression, and this apparent inverse relationship is not related to body mass index (BMI), a new study finds. On Monday the results will be presented at The Endocrine Society's 93rd Annual Meeting in Boston.
"Animal data suggest that leptin may reduce anxiety and improve depression. Our study in women suggests that leptin may indeed have antidepressant qualities," said the study's lead author, Elizabeth Lawson, MD, of Massachusetts General Hospital and Harvard Medical School ...
BSSA tip sheet for June 2011
2011-06-07
Buried mangrove layer dampens seismic shaking along Caribbean coasts
Engineers have long used a soft flexible layer, often made of rubber bearings, between a rigid building and the soil to reduce the impact of ground shaking on the structure. Now French scientists have determined that a buried mangrove layer along the coasts of Guadeloupe Island, close to the Caribbean subduction zone, serves a similar purpose. The mangrove swamps limit the effects of seismic waves on the uppermost sandy layer, reducing the potential of liquefaction from shaking caused by earthquakes. ...
Many of those living with HIV face a new life-threatening challenge: cancer
2011-06-07
CHICAGO – As the world marks the 30-year anniversary of the first reporting of HIV/AIDS, now comes the realization of a new challenge for people with the incurable disease. For reasons not yet clear, people with HIV face a higher rate of cancers not usually associated with HIV. This increasing rate of "non-AIDS defining cancers" includes lung, head and neck, liver, kidney, and anal cancers, among others. The alarming uptick in cancer rates highlights the critical need to understand how to treat tumors in people taking highly active anti-retroviral therapy (HAART) for ...
New strategy to attack tumor-feeding blood vessels
2011-06-07
Scientists at the Walter and Eliza Hall Institute have discovered a key molecule needed to kill the blood vessels that supply tumours.
The research team from the institute's Molecular Genetics of Cancer and Cancer and Haematology divisions found that for anti-cancer therapies that target tumour blood vessels to work the death- inducing molecule Bim is required. The finding could lead to improved anti-cancer treatments that are based on a two- or three-pronged attack on both the tumour and its blood supply. The research will be published online in the Journal of Experimental ...
Singapore researchers invent broadband graphene polarizer
2011-06-07
Researchers at the National University of Singapore have invented a graphene-based polarizer that can broaden the bandwidth of prevailing optical fibre-based telecommunication systems.
The graphene research team, led by Professor Kian Ping Loh at the National University of Singapore, invented an ultra-slim broadband polarizer that uses graphene, a single-atomic-layer crystallized carbon, to convert light beam into polarized light. This is the first experimental demonstration of using graphene as an ultrathin waveguide to couple and modulate light. Light modulation by ...